Sanofi Beats First Bellwether In Chemo Drug Hair Loss MDL
Sanofi was cleared of liability Thursday in the first bellwether trial in multidistrict litigation against drugmakers over claims that the chemotherapy drug Taxotere causes patients to lose their hair permanently....To view the full article, register now.
Already a subscriber? Click here to view full article